Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
scientific article published on 09 February 2016
Author/s
author: Hagop Kantarjian, Zeev Estrov, Jorge Eduardo Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, P. Andrew Futreal, Courtney D DiNardo, Naval Daver, Carlos B Bueso-Ramos, Curtis Gumbs, Koichi Takahashi, Keyur P Patel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.